4. BREAKDOWN OF SPENDING PROGRAMME
(continued)
4.3 Pharmaceutical Expenditure
4.3.1 What was pharmaceutical expenditure
in each year from 1997-98 to 2005-06, by sector and generic/branded
drugs? (Q52)
ANSWER
1. Total NHS net expenditure on medicines
and listed appliances in England is given in Table 52a.
In 2005-06, the total spent on prescriptions dispensed in the
community was £7,215 million—this is a provisional
figure and has yet to be finalised. Resource figures are not available
prior to 2001-02.
2. In cash terms, total NHS net expenditure
on medicines and listed appliances relating to prescriptions dispensed
in the community in England in 2005-06 was £7,232 million.
Again, this is a provisional figure and has yet to be finalised.
Table 52a
NHS NET EXPENDITURE ON MEDICINES AND LISTED
APPLIANCES, ENGLAND (RESOURCES)
|
| | |
£ millions |
| Year | Total NHS net
expenditure relating to
prescriptions
dispensed in the
community
| Total NHS net
expenditure relating
to medicines supplied
in a secondary care
setting
| Total NHS net
expnditure on
medicines and listed
appliances
|
|
| 2001-02 | 5,707
| 1,740 | 7,447
|
| 2002-03 | 6,342
| 2,013 | 8,355
|
| 2003-04 | 6,961
| 2,311 | 9,272
|
| 2004-05 | 7,370
| 2,595 | 9,965
|
| 2005-06 | 7,215(1)
| n/a(2) | n/a(2)
|
|
Footnotes:
1. Figure provisional and not yet finalised.
2. Figure not yet available.
3. Historical NHS Drug Bill expenditure figures (in cash
terms), broken down by sector, for the financial years 1997-98
to 2005-06 is provided in the Table 52b.
Table 52b
DRUGS BILL EXPENDITURE FIGURES (CASH)
|
| | |
£ millions |
| Year | Total NHS net
expenditure relating to
prescriptions
dispensed in the
community
| Total NHS net
expenditure relating
to medicines supplied
in a secondary care
setting
| Total NHS net
expnditure on
medicines and listed
appliances
|
|
| 1997-98 | 4,085
| 1,088 | 5,173
|
| 1998-99 | 4,339
| 1,211 | 5,550
|
| 1999-2000 | 4,833
| 1,369 | 6,202
|
| 2000-01 | 5,161
| 1,530 | 6,691
|
| 2001-02 | 5,552
| 1,740 | 7,292
|
| 2002-03 | 6,209
| 2,013 | 8,222
|
| 2003-04 | 6,799
| 2,308 | 9,107
|
| 2004-05 | 7,340
| 2,635 | 9,975
|
| 2005-06 | 7,232(1)
| n/a(2) | n/a(2)
|
|
Footnotes:
1. Figure provisional and not yet finalised.
2. Figure not yet available.
4. For prescriptions dispensed in the community in England,
a breakdown between branded medicines, generic medicines, dressings
and listed appliances for the financial years 1997-98 to 2005-06
is provided in Table 52c. The table shows both the cost
(expressed in terms of net ingredient cost) and the volume (number
of prescription items) for each category. In 2005-06, branded
drugs dispensed represent about 70% of the total net ingredient
cost (inc. the cost of dressings and appliances). In 2005-06,
the share of prescription items written generically was 80%, and
the share of prescription items dispensed generically was 59%.
Table 52c
NUMBER AND NET INGREDIENT COST OF GENERIC AND PROPRIETARY
PRESCRIPTION ITEMS DISPENSED IN THE COMMUNITY 1997-98 TO 2005-06
|
| | |
| | | £ millions
|
| Drugs dispensed generically
| Drugs dispensed as proprietary
| Dressings and Appliance
|
| Financial Year | NIC
| Prescription
items
| NIC | Prescription
items
| NIC | Prescription
items
|
|
| 1997-98 | 651
| 230 | 3,574
| 260 | 240
| 15 |
| 1998-99 | 703
| 240 | 3,845
| 261 | 251
| 15 |
| 1999-2000 | 1,049
| 254 | 4,116
| 265 | 270
| 15 |
| 2000-01 | 1,077
| 284 | 4,283
| 261 | 291
| 16 |
| 2001-02 | 1,079
| 300 | 4,886
| 275 | 316
| 17 |
| 2002-03 | 1,397
| 325 | 5,275
| 282 | 346
| 17 |
| 2003-04 | 1,799
| 359 | 5,488
| 282 | 378
| 18 |
| 2004-05 | 2,054
| 392 | 5,633
| 281 | 407
| 19 |
| 2005-06 | 2,042
| 427 | 5,523
| 286 | 449
| 20 |
|
Footnotes:
1. PCA, Prescription Pricing Division, England. Figures are
for prescription items dispensed by chemists and appliance contractors
and dispensing doctors including items personally administered
in England, for financial years (April to March). Note that in
addition to prescriptions written by GPs in England, this includes
those written by nurses, dentists, hospital doctors, (and, up
to March 1994, armed services doctors and dentists) provided they
were dispensed in the community. Also included are prescriptions
written in Wales, Scotland, Northern Ireland and the Isle of Man
but dispensed in England. The data do not cover drugs dispensed
in hospital, mental health trusts or private prescriptions. Please
note data for 2001-02 in the previous HSC was incorrect due to
errors in Prescription Cost Analysis (PCA). The data has now been
revised.
2. The net ingredient cost (NIC) is the basic cost of a drug.
This cost does not take account of discounts, dispensing costs,
fees or prescription charge income. All figures are expressed
at outturn prices.
3. Generic dispensing covers drugs that are prescribed and
available generically and the dispenser is reimbursed at the Drug
Tariff or generic price. It is possible in some circumstances
for a branded drug or parallel import to be dispensed against
the prescription.
4. The Department collects data on secondary care prescribing
through NHS Trust and Health Authority financial returns. On an
annual basis, these high level aggregate returns enable it to
monitor the pressure faced by local NHS organisations and the
aggregate cost to the NHS as a whole. More detailed information
is available to Trusts at a local level from hospital pharmacy
IT systems. This is primarily used to monitor local spending on
pharmaceuticals together with adherence to local policies aimed
at ensuring the cost effective use of medicines.
5. "Pharmacy in the Future", the modernisation programme
for pharmacy services in England made a commitment to secure better
use of medicines in the NHS and the Audit Commission published
their report "A Spoonful of Sugar" in December 2001
with recommendations.
6. Since then, the Department and the National Prescribing
Centre (NPC) have been helping NHS organisations improve their
medicines management services through the revised Medicines Management
Framework and the National Collaborative Medicines Management
Service Programme. The central aim is to ensure that clinicians,
pharmacists and financial planners work more closely together
across local health economies to involve patients in decisions
about their medicines so they know how to use them more effectively
to reduce avoidable ill health and waste.
7. The Medicines Management Services Collaborative (MMSC)
has worked with 146 PCTs throughout England. The Hospital Medicines
Management Collaborative (HMMC) has 44 Trusts currently participating
in the programme, the Community Pharmacy Framework Collaborative
(CPFC) has 28 host PCTs participating in the programme together
with a number of associate PCTs and the Integrated Medicines Management
Programme (IMMP) currently has 25 Trusts participating.
4.4 National Specialist Services (NSCAG)
4.4.1 Could the Department detail actual and planned
expenditure on supra-regional and centrally commissioned services
in each year from 2003-04 to 2007-08? (Q53)
ANSWER
1. Actual expenditure between 2003-04 and 2005-06 is
given in Table 53. Full details of planned expenditure
for 2006-07 should be available by the end of September. 2007-08
information can be provided when final budgets are confirmed and
negotiations with Trusts are complete. We would expect this to
be early in financial year 2007-08.
|
